AXT slips 3.4% as investors revisit dilution and China export-permit overhang

AXT, Inc. (AXTI) is down 3.4% today. Here is some analysis on what might have caused this price movement.

Analysis: There does not appear to be a single, company-issued headline driving today’s dip; the move looks consistent with a pullback after a volatile stretch. Selling pressure could be tied to lingering dilution concerns from AXT’s recent equity offering and ongoing uncertainty around China export permits that have been affecting indium phosphide shipments, alongside investor digestion of the company’s latest quarterly results.

Details:

AXT closed an underwritten public offering of 8,163,265 shares (including the underwriters’ full overallotment) at $12.25 per share, a deal structure that can weigh on sentiment due to dilution and increased float.

In early January 2026, the company reduced its fourth-quarter 2025 revenue expectations, citing fewer-than-expected export control permits for indium phosphide being issued by China’s Ministry of Commerce.

In its February 19, 2026 earnings release for Q4 and full-year 2025, AXT reported Q4 revenue of $23.0 million and discussed the export-permit headwind while positioning indium phosphide demand as tied to AI infrastructure build-outs.

This could also be amplified by routine profit-taking after sharp prior moves, particularly in smaller-cap semiconductor names where liquidity can magnify day-to-day swings.

Sources:

AXT Investor Relations, SEC (EDGAR)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$AXTI Insider Trading Activity

$AXTI insiders have traded $AXTI stock on the open market 33 times in the past 6 months. Of those trades, 0 have been purchases and 33 have been sales.

Here’s a breakdown of recent trading of $AXTI stock by insiders over the last 6 months:

MORRIS S YOUNG (CEO) has made 0 purchases and 9 sales selling 547,756 shares for an estimated $17,101,998.
GARY L FISCHER (CFO) has made 0 purchases and 6 sales selling 293,239 shares for an estimated $6,441,054.
JESSE CHEN has made 0 purchases and 10 sales selling 99,812 shares for an estimated $4,325,687.
DAVID C CHANG has made 0 purchases and 7 sales selling 235,000 shares for an estimated $4,300,347.
LEONARD J LEBLANC sold 3,637 shares for an estimated $30,587

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$AXTI Hedge Fund Activity

We have seen 84 institutional investors add shares of $AXTI stock to their portfolio, and 25 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DAVIDSON KEMPNER CAPITAL MANAGEMENT LP added 2,734,693 shares (+inf%) to their portfolio in Q4 2025, for an estimated $44,712,230
HOOD RIVER CAPITAL MANAGEMENT LLC added 2,012,228 shares (+inf%) to their portfolio in Q4 2025, for an estimated $32,899,927
PACIFIC RIDGE CAPITAL PARTNERS, LLC removed 1,793,797 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $29,328,580
FIRST BEIJING INVESTMENT LTD removed 1,730,156 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $28,288,050
POINT72 ASSET MANAGEMENT, L.P. added 1,516,156 shares (+inf%) to their portfolio in Q4 2025, for an estimated $24,789,150
CLOUDALPHA CAPITAL MANAGEMENT LIMITED/HONG KONG added 1,390,730 shares (+inf%) to their portfolio in Q4 2025, for an estimated $22,738,435
ALYESKA INVESTMENT GROUP, L.P. added 1,234,693 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,187,230

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$AXTI Analyst Ratings

Wall Street analysts have issued reports on $AXTI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

B. Riley Securities issued a "Buy" rating on 10/31/2025

To track analyst ratings and price targets for $AXTI, check out Quiver Quantitative's $AXTI forecast page.

$AXTI Price Targets

Multiple analysts have issued price targets for $AXTI recently. We have seen 3 analysts offer price targets for $AXTI in the last 6 months, with a median target of $21.0.

Here are some recent targets:

Matt Bryson from Wedbush set a target price of $28.0 on 02/20/2026
Dave Kang from B. Riley Securities set a target price of $21.0 on 02/20/2026
Charles Shi from Needham set a target price of $10.0 on 10/31/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.